WODC 2023

WODC 2023 Complete Coverage

hATTR News Briefs

Select Policies May Interfere With Patient Access to Therapies

By

Ashley Lyles

Publish Date May 30, 2023

Access and policy challenges may interfere with rare disease patients’ ability to receive select therapies in the US and Europe, experts at WODC suggested.

WODC 2023

Genome Sequencing Tests May Improve Diagnosis of Rare Diseases

By

Ashley Lyles

Publish Date May 30, 2023

Genome sequencing tests may be useful in the diagnosis of rare diseases, according to a session at the 2023 World Orphan Drug Congress.

WODC 2023

Panel: Newborn Screening and Genetic Sequencing Face Equity Challenges

By

Ashley Lyles

Publish Date May 25, 2023

Newborn screening and genetic sequencing are useful tools for patient care and treatment, but equity-related challenges should be addressed, experts said.

WODC 2023

Newborn Screening May Lessen Time to Diagnosis and Drive Stakeholder Support

By

Ashley Lyles

Publish Date May 25, 2023

Newborn sequencing may shorten a patient’s diagnostic odyssey, experts said at the 2023 World Orphan Drug Congress (WODC).

WODC 2023

Artificial Intelligence Could Help Identify Patients With Rare Diseases

By

Ashley Lyles

Publish Date May 25, 2023

Identifying patients with rare diseases and connecting them to the appropriate clinician can be challenging, panelists at WODC suggested.

SMA News Briefs

Streamlined Approach to Developing Rare Disease Therapies Being Examined

By

Ashley Lyles

Publish Date May 25, 2023

Initiatives are underway to streamline the pathway to new treatments for rare diseases, a federal health official said at WODC 2023.